Physician profile
Benjamin Hocutt
NPI 1063817773
$25,344.26
in general payments reported to CMS, 2019-2025
17 companies · $8,316 in 2025
The $8,316 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $978 · 2022: $563 · 2023: $6,178 · 2024: $9,310 · 2025: $8,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,780 · Food and Beverage: $3,387 · Travel and Lodging: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,520.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,780.00 |
| Food and Beverage | $3,386.78 |
| Travel and Lodging | $1,117.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $11,817.87 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $9,017.58 | 2023-2025 | Inpefa |
| Merck Sharp & Dohme LLC | $1,549.88 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $918.64 | 2021-2023 | |
| Abbott Laboratories | $831.12 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Cardiomems |
| Abiomed | $485.94 | 2022-2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $165.45 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $133.45 | 2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $133.24 | 2021-2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.42 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.13 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.07 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $30.16 | 2021-2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $26.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.71 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.58 | 2021 | |
| Medtronic, INC. | $18.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Hocutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.